A recent article in Cell reported a new form of modified rabies virus that was apparently capable 11 of labeling neurons "without adverse effects on neuronal physiology and circuit function". These 12 "self-inactivating" rabies ("SiR") viruses differed from the widely-used first-generation deletion-13 mutant (∆G) rabies viruses only by the addition of a destabilization domain to the viral 14 nucleoprotein. However, we observed that the transsynaptic tracing results from that article were 15 inconsistent with the logic described in it, and we hypothesized that the viruses used were actually 16 mutants that had lost the intended modification to the nucleoprotein. We obtained samples of two 17 SiR viruses from the authors and show here that, in both "SiR-CRE" and "SiR-FLPo", the great 18 majority of viral particles were indeed mutants that had lost the intended modification and were 19 therefore just first-generation, ∆G rabies viruses. We also found that SiR-CRE killed 70% of 20 infected neurons in vivo within two weeks. We have shown elsewhere that a ∆G rabies virus 21 encoding Cre can leave a large percentage of labeled neurons alive; we presume that Ciabatti et 22 al. found such remaining neurons at long survival times and mistakenly concluded that they had 23 developed a nontoxic version of rabies virus. Here we have analyzed only the two samples that 24 were sent to MIT by Ciabatti et al., and these may not be from the same batches that were used 25 for their paper. However, 1) both of the two viruses that we analyzed had independently lost the 26 intended modification, 2) the mutations in the two samples were genetically quite distinct from 27 each other yet in both cases caused the same result: total or near-total loss of the C-terminal 28 modification, and 3) the mutations that we found in these two virus samples perfectly explain the 29 otherwise-paradoxical transsynaptic tracing results from Ciabatti et al.'s paper. We suggest that 30 the SiR strategy, or any other such attempt to attenuate a virus by addition rather than deletion, 31 is an inherently unstable approach that can easily be evaded by mutation, as it was in this case.
INTRODUCTION

35
Monosynaptic tracing based on deletion-mutant rabies virus has become an important tool in 36 neuroscience since its introduction in 2007 (Wickersham et al., 2007b and remains the only way 37 of labeling neurons directly presynaptic to some targeted neuronal group in the absence of prior 38 hypotheses (Augustine et al., 2018; Evans et al., 2018; Kaelberer et al., 2018; Kohl et al., 2018) .
As seen in Figure 1 , we found that the cells infected with the SiR viruses looked very 153 similar to those infected with the first-generation, ∆G viruses. Notably, the viral nucleoprotein, 154 which in the SiR viruses is supposed to be destabilized and degrade rapidly in the absence of 155 TEVP, accumulated in the SiR-infected cells in clumpy patterns that looked very similar to those 156 in the cells infected with the first-generation, ∆G viruses. By contrast, the cells infected with the 157 second-generation, ∆GL viruses, which we have shown is actually attenuated and really does not 158 kill cells (Chatterjee et al., 2018) , did not show any such nucleoprotein accumulation, clumped or 159 otherwise, only punctate labeling presumably indicating isolated viral particles or post-infection 160 uncoated viral particles (ribonucleoprotein complexes) that really are not replicating.
162
Longitudinal two-photon imaging in vivo 163 164 To see whether the SiR viruses kill neurons in the brain, we conducted longitudinal two-165 photon imaging in vivo of virus-labeled neurons in visual cortex of tdTomato reporter mice, as we 166 had done previously to demonstrate the nontoxicity of second-generation rabies virus(Chatterjee 167 et al., 2018) ( Figure 2 ). Because the SiR viruses were EnvA-enveloped, we first injected a 168 lentivirus expressing EnvA's receptor TVA, then one week later we injected either SiR-CRE or 169 one of two EnvA-enveloped viruses made in our laboratory: the first-generation virus RV∆G-170 4Cre(EnvA) or the second-generation virus RV∆GL-4Cre(EnvA). Beginning one week after rabies 171 virus injection, we imaged labeled neurons at the injection site every seven days for four weeks, 172 so that we could track the fate of individual neurons over time.
173
As we have found in our previous work (Chatterjee et al., 2018) , our second-generation 174 virus RV∆GL-4Cre did not kill neurons to any appreciable degree: all but a tiny handful of the 175 neurons labeled by this virus at 7 days after injection were still present three weeks later in all 176 mice. Again as we have found previously (Chatterjee et al., 2018) , our first-generation virus RV∆G-177 4Cre did kill neurons, but by no means all of them.
178
However, we found that the putatively nontoxic SiR-CRE caused a steep loss of neurons 179 much more pronounced than even our first-generation virus did. By 14 days after injection, 70% 180 of cells seen at 7 days were dead; by 28 days, 81% were.
181
There is a possible confound from our use of the tdTomato reporter line Ai14 (which we 182 used primarily because we already had large numbers of mice of this line): because SiR-CRE is 183 actually "SiR-iCRE-2A-mCherryPEST", designed to coexpress mCherry (with an added C-184 terminal PEST domain intended to destabilize it, as for the nucleoprotein) along with Cre, it is 185 conceivable that some of the SiR-CRE-labeled red cells at 7 days were only expressing mCherry 186 and not tdTomato. If the destabilized mCherry were expressed only transiently, as Ciabatti et al.
187
intended it to be (Ciabatti et al., 2017) , and a significant fraction of SiR-CRE virions had mutations 188 in the Cre gene so they did not express functioning Cre, then it is possible that some of the red 189 cells seen at 7 days were labeled only with mCherry that stopped being visible by 14 days, so 190 that it would only look like those cells had died.
191
We viewed this alternative explanation as unlikely, because Ciabatti et al. injected CRE in an EYFP reporter line and found no cells labeled only with mCherry and not EYFP at 6 193 days and 9 days postinjection (see Figure S4 in Ciabatti et al.) . Nevertheless, we addressed this 194 potential objection in several ways.
195
First, we sequenced the transgene inserts (iCre-P2A-mCherryPEST) of 21 individual SiR-196 CRE viral particles (see Supplementary File S1) and found that only 2 out of 21 had mutations in 197 the Cre gene, suggesting that there would not have been a large population of cells only labeled 198 by mCherry and not tdTomato.
199
Second, we simply redid some of the SiR-CRE injections and imaging in a different 200 reporter line: Ai35, expressing Arch-EGFP-ER2 after Cre recombination (Madisen et al., 2012) 201 (Jax 012735). Although we found that the membrane-localized green fluorescence from the Arch-202 EGFP-ER2 fusion protein unfortunately was too dim and diffuse at 7 days postinjection for us to get clear images, we were able to obtain clear images of a number of cells at 11 days 204 postinjection. We found that 46% of them had disappeared only three days later (see 205 Supplementary Video S1 and Supplementary Figure S2 ), and 86% had disappeared by 28 days 206 postinjection, consistent with a rapid die-off. Furthermore, we found that the red fluorescence in 207 Ai35 mice, which was due only to the mCherry expressed by the virus, was much dimmer than 208 the red fluorescence in Ai14 mice at the same time point of 7 days postinjection and with the same 209 imaging parameters (see Supplementary Figure S1 ): the mean intensity was 45.86 (arbitrary 210 units, or a.u.) in Ai14 but only 16.29 a.u. in Ai35. This is consistent with the published findings that 211 tdTomato is a much brighter fluorophore than mCherry (Shaner et al., 2004) , particularly with two-212 photon excitation (Drobizhev et al., 2011) , and it is also consistent with Ciabatti et al.'s addition of 213 a destabilization domain to mCherry's C-terminus (although we also observed that there were still 214 red fluorescent cells present at week 4 in Ai35 (data not shown)). We therefore redid the counts 215 of labeled cells in our Ai14 datasets to include only cells with fluorescence at 7 days of more than 216 32.33 a.u., the midpoint of the mean intensities in Ai35 versus Ai14 mice, in order to exclude 217 neurons that might have been labeled with mCherry alone. As seen in Figure S3 , restricting the 218 analysis to the cells that were brightest at 7 days (and therefore almost certainly not labeled with 219 just mCherry instead of either just tdTomato or a combination of both mCherry and tdTomato) 220 made no major difference: 70.0% of SiR-labeled neurons had disappeared by 14 days, and 80.8%
221
were gone by 21 days.
223
Sequencing of viral genomes: Sanger sequencing
225
In order to directly test our hypothesis that the SiR viruses had developed premature stop 226 codons removing the PEST domain in a majority of viral particles, we sequenced the genomes of 227 a large number of individual viral particles using two different techniques.
228
First, we used ordinary Sanger sequencing to determine the sequence in the vicinity of 229 the end of the nucleoprotein gene for 50 -51 individual viral particles of each of the two SiR 230 viruses and for a first-generation virus from our own laboratory, RV∆G-4mCherry ( Figure 3 ). We 231 ensured the isolation of individual viral genomes by using a primer with a random 8-base index 232 for the reverse transcription step, so that the cDNA copy of each RNA viral genome would have 233 a unique index. Following the reverse transcription step, we amplified the genomes by standard 234 PCR, cloned the amplicons into a generic plasmid, transformed this library into E.coli and 235 sequenced plasmids purified from individual colonies. As shown in Figure 3 , the results confirmed 236 that our hypothesis was correct.
237
In the SiR-CRE sample, 100% of the 51 sequenced viral particles had lost the PEST 238 domain. 50 out of the 51 had the same point mutation in the linker between the end of the native 239 nucleoprotein gene and the TEVP cleavage site, converting a glycine codon (GGA) to a stop 240 codon (TGA) so that the only modification to the C-terminus of the nucleoprotein was the addition 241 of two amino acids (a glycine and a serine). The one sequenced viral particle that did not have 242 this point mutation had a single-base insertion in the second-to-last codon of the native 243 nucleoprotein gene, frameshifting the rest of the sequence and resulting in 15 amino acids of 244 nonsense followed by a stop codon before the start of the PEST domain sequence.
245
In the SiR-FLPo sample, the situation was somewhat more interesting: out of 50 246 sequenced viral particles, 18 had the same stop codon that was found in almost all genomes in 247 the Cre sample, while another 28 had a different stop codon three amino acids upstream,
248
immediately at the end of the native nucleoprotein gene (converting a serine codon (TCA) to a 249 stop codon (TGA). Four viral particles had no mutations in the sequenced region. Thus 46/50 250 (92%) of the SiR-FLPo viral particles sequenced had lost the PEST domain.
251
In contrast, in the first-generation virus from our own lab, RV∆G-4mCherry, none of the 50 252 viral particles sequenced had mutations in the sequenced region on the end of the nucleoprotein 253 gene.
255
Sequencing of viral genomes: Single-molecule, real-time (SMRT) sequencing
257
As a second approach to analyzing the mutations present in the SiR viruses, we employed 258 an advanced large-scale sequencing technology: single-molecule, real-time ("SMRT") 259 sequencing, which provides independent sequences of tens of thousands of individual single 260 molecules in a sample in parallel ( Figure 4 ). The results from this advanced sequencing method 261 were quite consistent with the results from the Sanger sequencing presented above. As with the 262 sample preparation for Sanger sequencing, we included a random (10 bases in this case) index 263 in the reverse transcription primer, again so that the cDNA copy of each RNA viral genome 264 molecule would be labeled with a unique index.
265
SMRT sequencing entails circularization of the DNA molecules and multiple consecutive 266 passes around the resulting circular molecule, with the redundancy provided by this repeated 267 sequencing of each position increasing the signal to noise ratio and statistical significance of the 268 results. The numbers presented in Figure 4 and below use the default of including only clones 269 that had at least three reads of each base ("circular consensus sequence 3", or "CCS3" in 270 Supplementary File S3). Using the increasingly stringent criteria of requiring either five or eight 271 reads per base (CCS5 or CCS8) reduced the numbers of qualifying genomes in all cases and 272 changed the percentages slightly but gave overall very similar results. Because read accuracy for 273 SMRT sequencing is ≥98% (circular consensus sequencing with 3 passes (see 274 https://www.mscience.com.au/upload/pages/pacbio/technical-note---experimental-design-for-275 targeted-sequencing.pdf), we used a conservative threshold of 2% frequency of any given point 276 mutation position in order to screen out false positives. Also to be very conservative, for Figure 4 277 we ignored all apparent frame shifts caused by insertions and deletions, because insertions in 278 particular are prone to false positives with SMRT sequencing (Carneiro et al., 2012) . See
279
Supplementary File S3 for details, including details of frameshifts due to insertions;
280
Supplementary Files S4-S6 contain the sequences of the PCR amplicons that would be expected 281 based on published sequences of the three viruses. In summary:
282
As a control, we used a virus from our own laboratory, RV∆G-4Cre(Chatterjee et al., 2018) 283 (see Addgene #98034 for reference sequence). Out of 17,978 sequenced genomes of this virus, 284 we found no mutations above threshold frequency at the end of N. We did find that 1,706 viral 285 particles (9.49%) had a nonsynonymous mutation (TCT (Ser) -> ACT (Thr)) farther up in N at 286 amino acid position 419 (31 amino acids upstream of the end of the 450-aa native protein). We 287 do not know if this mutation is functionally significant, although it is not present in CVS 
311
Here we have shown that the likely explanation is that the SiR viruses have simply lost the 312 intended C-terminal modification of the nucleoprotein.
313
We do not believe that the escape of the SiR viruses from the modification intended to 314 attenuate them was a fluke due to bad luck with a couple of batches, for the following reasons.
315
First, both of the two SiR virus samples to which we had access had independently developed 316 mutations causing loss of the intended C-terminal addition to the nucleoprotein, and, because the 317 two samples were of completely different viruses (one was SiR-CRE; the other SiR-FLPo), the 318 two viruses clearly had each independently escaped the intended modification rather than both 319 deriving from a single compromised parental stock. Second, the mutation profiles of the two 320 viruses were quite different: whereas the SiR-CRE sample had the same point mutation in nearly 321 100% of its viral particles, only a minority of the SiR-FLPo particles had that particular mutation, 322 with the majority having a different point mutation three codons away that had the same result.
323
This suggests that any of the many opportunities for removing the C-terminal addition -creation 324 of a premature stop codon at any one of a number of sites, a frameshift mutation anywhere in the 325 vicinity, or any combination of these -can be exploited by a given batch of virus, greatly 326 increasing the probability of such mutants arising and dominating the population. Third, the harbored exactly the kind of mutations we found in the two preparations to which we did have 331 access. We would therefore predict that any SiR preparation that has been found to be capable 332 of efficient transsynaptic spread under the conditions described in Ciabatti et al. will be found 333 either to consist primarily of "escape mutants" similar to those that we have described here or, as 334 we discuss below, to have developed such mutations in vivo.
335
It may be that, given sufficient care and expertise, it is possible under some circumstances 336 to make SiR virus with the intended C-terminal addition intact. This to some extent is beside the 337 point. What we would predict, to restate the above, is that any SiR virus that does retain the 
342
However, even if a pure SiR viral preparation were able to be made and sequence-verified 343 before injection, the kinds of reversion mutations that we have shown here could just as easily 344 occur in vivo as the virus replicated within the starting postsynaptic neurons, so that the virus 345 would once again revert to the toxic, unmodified ∆G version. These mutations in situ would be 346 very difficult to detect, short of extracting the viral genomes from labeled cells and sequencing 347 them.
348
Given that the SiR samples that we analyzed were in fact just first-generation ∆G viruses, 
355
found that a replication-competent rabies virus expressing Cre also allowed long-term survival of some neurons (Gomme et al., 2012) ). Interestingly, although we have not done similarly 357 painstaking quantitative studies of a first-generation (∆G) virus expressing Flpo, it appears that 358 the FLPo-expressing version is not comparably nontoxic (Supplementary Figure S4 ). This is still 
366
The most obvious explanation for why a simple ∆G rabies virus encoding Cre can leave 367 many cells alive is that Cre is for some reason less toxic than tdTomato, EGFP, channelrhodopsin, 368 or other payloads. It might be, for example, that the nuclear localization of Cre causes its rapid 369 accumulation to activate less of an immune response than does that of the cytoplasmic or 370 membrane-bound proteins like EGFP. This would suggest that addition of a nuclear localization 371 signal to, e.g., tdTomato would render a ∆G vector encoding it to be less toxic. We have not tested 372 this possibility, but our finding that a ∆G vector encoding FLPo, which is also nuclearly-localized,
373
does not seem to share the reduced toxicity of RV∆G-Cre (Supplementary Figure S4 ) might 374 appear to argue against this explanation.
375
It may be that the primary reason for the reduced toxicity of the first-generation ∆G vectors 376 encoding Cre is, fittingly, the same high mutation rate that we have highlighted in this paper. We virus, which has the polymerase gene L deleted in addition to the glycoprotein gene G, leaves 379 cells alive indefinitely. However, any first-generation (∆G) vector that develops a frameshift or 380 point mutation knocking out L is in practice a ∆GL vector. Indeed, a stop codon or frameshift 381 mutation in the nucleoprotein or phosphoprotein genes is likely to have a similar effect as one in 382 L (and it might be that the Ser419Thr mutation that we found in 9.49% of our RV∆G-4Cre virions 383 is just such a knockout mutation of N). Together with the high mutation rate of rabies virus, this 384 means that, within every preparation of first-generation rabies virus there is almost guaranteed to 385 be a large population of de facto second-generation variants mixed in with the intended first-386 generation population and propagated in the producer cells by complementation by the first-387 generation virions. While any rabies virus preparation (whether made in the laboratory or 388 occurring naturally) can be expected to contain a large fraction of such knockout (whether by 389 substitution, frameshift, or deletion) mutants (classically known as "defective interfering particles" 390 (Clark et al., 1981; Kawai and Matsumoto, 1977; Wiktor et al., 1977) ; the higher the multiplicity of 391 infection when passaging the virus, the higher the proportion of such freeloading viral particles 392 typically will be), this would not necessarily be noticed in the case of a virus encoding some more 393 typical transgene product such as EGFP or tdTomato, because the expression levels of these by 394 the knockout mutants would be too low to label cells clearly (see Figure 1 in Chatterjee et 395 al. (Chatterjee et al., 2018) ). However, with Cre as the transgene, these "second-generation" 396 particles can label neurons, which would then not die off, whereas the ones infected by the actual 397 first-generation particles (i.e., those that have all their viral genes intact apart from the deleted G) 398 presumably do die. This explanation would predict that the percentage of neurons surviving 399 infection with a rabies virus encoding Cre (or presumably FLPo) will depend on the particular viral 400 preparation that is injected, with some presumably having a greater fraction of knockout particles 401 than others.
402
Finally, generalizing from our findings in the specific case we have examined here: we 403 suggest that the SiR approach, or any other such attempt to attenuate a virus by addition rather 404 than deletion, and particularly by addition to the C terminus of a viral protein, is an inherently 405 unstable strategy. Any such modification can so easily be lost by mutation (by creation of either 406 a stop codon or a frameshift), and any mutant that loses it will immediately possess a replication advantage over the attenuated virions so can quickly dominate the population, as we have shown 408 happened with the SiR viruses. 
432
The first-generation vector genome plasmid pRV∆G-4FLPo was made by cloning the FLPo 433 gene(Raymond and Soriano, 2007) into pRV∆G-4Cre.
435
The above novel plasmids have been deposited with Addgene with accession numbers 115234, Co.) with a hand warmer (Heat Factory) underneath the animal to maintain body temperature.
493
Following disinfection with povidone-iodine, an incision was made in the scalp, and a 3 mm 494 craniotomy was opened over primary visual cortex (V1). 300 nl of LV-U-TVA950(B19G) (see 495 above) was injected into V1 (-2.70 mm AP, 2.50 mm LM, -0.26 mm DV; AP and LM stereotaxic 496 coordinates are with respect to bregma; DV coordinate is with respect to brain surface) using a 497 custom injection apparatus comprised of a hydraulic manipulator (MO-10, Narishige) with 498 headstage coupled via custom adaptors to a wire plunger advanced through pulled glass 499 capillaries (Wiretrol II, Drummond) back-filled with mineral oil and front-filled with virus solution.
500
Glass windows composed of a 3mm-diameter glass coverslip (Warner Instruments CS-3R) glued 501 (Optical Adhesive 61, Norland Products) to a 5mm-diameter glass coverslip (Warner Instruments 502 CS-5R) were then affixed over the craniotomy with Metabond (Parkell). Seven days after injection 503 of the lentiviral vector, the coverslips were removed and 300 nl of one of the three EnvA-504 enveloped rabies viral vectors (with equalized titers as described above) was injected at the same 505 stereotaxic coordinates. Coverslips were reapplied and custom stainless steel headplates 506 (eMachineShop) were affixed to the skulls around the windows.
508
In vivo two-photon imaging and image analysis a maximum of four weeks following rabies virus injection, the injection sites were imaged on a 511 Prairie/Bruker Ultima IV In Vivo two-photon microscope driven by a Spectra Physics Mai-Tai Deep 512 See laser with a mode locked Ti:sapphire laser emitting at a wavelength of 1020 nm for tdTomato 513 (or mCherry) or 920 nm for EGFP. Mice were reanesthetized and mounted via their headplates 514 to a custom frame, again with ointment applied to protect their eyes and with a handwarmer 515 maintaining body temperature. One field of view was chosen in each mouse in the area of maximal 
558
PCR procedure can amplify only the negative-sense RNA genome: the reverse transcription 559 primer is designed to anneal to the leader sequence of the negative-strand genome so that cDNA 560 synthesis can start from the negative-sense RNA genome, with no other possible templates.
561
Additionally, the PCR amplifies the cDNA, not any plasmids which were transfected into producer 562 cell lines during viral vector production, because the forward PCR primer anneals to the primer 563 used in the reverse transcription, rather than any viral sequence. This RT-PCR protocol ensures 564 that only negative-sense RNA rabies viral genomes can be sequenced.
566
Sanger sequencing of transgenes in SiR viruses
567
The procedure for sequencing the transgene inserts was the same as above, but with the RT 568 primer being Adaptor_N8_M_fp (see below), annealing to the M gene and again with a random 569 8-nucleotide index to tag each clone, and with PCR primers pEX_adaptor_fp (see above) and 570 Barcode2_L_rp (see below), to amplify the sequences from the 3' end of the M gene to the 5' end 571 of the L gene, covering the iCre-P2A-mCherryPEST (or FLPo-P2A-mCherryPEST) sequence.
573
Primers for RT and PCR for Sanger sequencing were as follows: 
632
After the amplicons were extracted and purified from an agarose gel, the three were mixed 633 together at 1:1:1 molar ratio. (A) Schematic of workflow for SMRT sequencing. An RT primer with a random 10-nucleotide sequence anneals to the leader sequence on the negative-sense single-stranded RNA genome. Forward and reverse PCR primers have distinct SMRT barcodes at their 5' ends for the three different virus samples. After RT-PCR, each amplicon library consists of amplicons each containing a SMRT barcode to identify the sample of origin as well as the 10nucleotide index (i.e., with a potential diversity of 4 10 different indices) to uniquely label the individual genome of origin. SMRT "dumbbell" adaptors are then ligated to the amplicons' ends, making circular templates which are then repeatedly traversed by a DNA polymerase, resulting in long polymerase reads each containing multiple reads of the positive and negative strands. 
LEGENDS FOR SUPPLEMENTARY INFORMATION
Supplementary File S1: >90% of SiR-CRE viral particles with the mCherry gene intact also have the Cre gene intact, suggesting that most of the SiR-CRE-infected cells that disappear over time in tdTomato reporter mice are dying rather than simply stopping expression of mCherry. We sequenced the transgene inserts for 21 individual SiR-CRE clones (see Methods). 19 out of 21 had no mutations in the Cre gene, and two had one point mutation each (Ala88Val and Arg189Ile). All 21 had an intact mCherry gene. The lack of a large proportion of Cre-knockout mutants is one indication that the majority of red fluorescent neurons in SiR-CRE-injected Ai14 (tdTomato reporter) mice are not labeled only with mCherry, providing evidence that their disappearance is equivalent to their death. Parenthetically, we also partially sequenced the transgene insert for four individual clones of the SiR-FLPo sample, just to confirm the identity of the virus. In one of the four sequenced virions, we found a 15 bp deletion in the FLPo gene as well as a synonymous Thr -> Thr (ACC -> ACA) substitution at position 47 of the mCherry gene; in another, we found a Gly -> Ser mutation at position 4 of the mCherry gene. We did not find mutations in the transgenes of other two SiR-FLPo genomes sequenced (data not shown). Figure S1 : mCherry fluorescence from SiR-CRE is much dimmer than tdTomato fluorescence in Ai14 mice, suggesting that the disappearance of the brighter cells in SiR-CRE-injected Ai14 mice indicates their death. A) Representative images of red fluorescence in SiR-CRE-labeled cells in Ai14 (Cre-dependent expression of tdTomato, top row) and Ai35 (Cre-dependent expression of Arch-EGFP-ER2, bottom row). The three images for each mouse line are from 3 different mice of each line, imaged 7 days following SiR-CRE injection (see Methods), all with the same laser intensity and wavelength (1020 nm). Red fluorescence due only to mCherry (i.e., in Ai35 mice) is obviously much dimmer than that due to tdTomato (i.e., in Ai14 mice). Scale bar: 50 µm, applies to all images. B) Intensity of red fluorescence of SiR-CRE-labeled cells in Ai14 (left) and Ai35 (right) mice. Data point indicate intensity of individual cells in arbitrary units at the same laser and microscope settings (see Methods). Box plots indicate median, 25th-75th percentiles (boxes), and full range (whiskers) of intensities for each mouse. The average of the mean red fluorescent intensity in each mouse was 48.97 in Ai14 and 15.69 in Ai35 (p=0.00283 < 0.01, one-way ANOVA); the midpoint of these means, 32.33, was used as the cutoff for the reanalysis of the data in Ai14 mice to exclude neurons that could have been labeled with mCherry alone.
Supplementary
Supplementary Video S1: Video of 95% of SiR-CRE-labeled neurons in an Arch-EGFP-ER2 reporter mouse disappearing between 11 days and 28 days postinjection. Two-photon image stacks of a single FOV of visual cortical neurons in an Ai35 mouse imaged at four different time points; time in the video represents depth of focus. Large blobs are glia. 18 out of the 19 neurons visibly labeled with Arch-EGFP-ER2 at 11 days following injection of SiR-Cre are no longer visible 17 days later. White circles indicate cells present at both 11 days and all subsequent imaging sessions; red circles indicate cells present at 11 days but gone by 28 days.
Supplementary Figure S2: 86% of SiR-CRE-labeled neurons in Arch-EGFP-ER2 reporter mice disappear between 11 days and 28 days after injection.
A) Maximum intensity projections of the two-photon FOV shown in Supplementary Video S1 of visual cortical neurons labeled with SiR-CRE in an Ai35 mouse, 11-28 days postinjection. Images are from the same FOV at four different time points. All cells clearly visible on day 11 are circled. In this example, 18 out of 19 cells ( A) Same representative fields of view as in Figure 2 but with circles now marking only cells with intensity at 7 days of greater than 32.33 a.u. (see text and Supplementary Figure S1 ) that are no longer visible at a subsequent time point. Scale bar: 50 µm, applies to all images. B-D) Numbers of cells above threshold fluorescence intensity at week 1 that were still present in subsequent weeks. The conclusions from Figure 2 are unchanged: few cells labeled with RV∆GL-4Cre were lost, RV∆G-4Cre killed a significant minority of cells, and SiR-CRE killed the majority of labeled neurons within two weeks following injection. E) Percentages of cells above threshold at week 1 that were still present in subsequent imaging sessions. By 28 days postinjection, an average of only 19.2% of suprathreshold SiR-CRE-labeled cells remained. Figure 3 . 51 clones derived from SiR-CRE, 50 from SiR-FLPo, and 51 from RV∆G-4mCherry are identified by their unique indices. All of the indices as well as the sequences corresponding to the 3' end of the nucleoprotein gene are shown.
Supplementary File S2: Sanger sequencing data of all clones shown in
Supplementary File S3: Summary tables of SMRT sequencing data. These tables show all mutations occurring at positions mutated at greater than 2% frequency in the three virus samples analyzed. Position numbers in these tables refer to the sequences in the three Genbank files below (Supplementary Files S4-S5).
Supplementary File S4: SiR-CRE amplicon reference sequence. This Genbank-format file contains the expected (i.e., based on the published sequence: Addgene #99608) sequence of amplicons obtained from SiR-CRE for SMRT sequencing.
Supplementary File S5: SiR-FLPo amplicon reference sequence. This Genbank-format file contains the expected (i.e., based on the published sequence: Addgene # 99609) sequence of amplicons obtained from SiR-FLPo for SMRT sequencing.
Supplementary File S6: RV∆G-4Cre amplicon reference sequence. This Genbank-format file contains the expected (i.e., based on the published sequence: see Addgene #98034) sequence of amplicons obtained from RV∆G-4Cre for SMRT sequencing. Figure S4 : First-generation vector RV∆G-4FLPo appears to be toxic to most cells, unlike the comparable first-generation vector RV∆G-Cre. Although we did not rigorously quantify the effect, our FLPo-encoding RV∆G-4Flpo appears to kill neurons more quickly than does RV∆G-4Cre (cf. Figure 2 and Chatterjee et al. (Chatterjee et al., 2018) ). In this example field of view, most neurons clearly visible at earlier time points have disappeared by 28 days postinjection, leaving degenerating cellular debris. See Discussion for possible reasons why a preparation of a first-generation vector encoding a recombinase may or may not preserve a large percentage of infected neurons. Scale bar: 50 µm, applies to all panels. CGGCCGCGGTACCGCCACCATGGTGCCCAAGAAGAAGAGGAAAGTCTCCAACCTGCTGACTGTGCACCAAAAC  CTGCCTGCCCTCCCTGTGGATGCCACCTCTGATGAAGTCAGGAAGAACCTGATGGACATGTTCAGGGACAGGCA  GGCCTTCTCTGAACACACCTGGAAGATGCTCCTGTCTGTGTGCAGATCCTGGGCTGCCTGGTGCAAGCTGAACA  ACAGGAAATGGTTCCCTGCTGAACCTGAGGATGTGAGGGACTACCTCCTGTACCTGCAAGCCAGAGGCCTGGC  TGTGAAGACCATCCAACAGCACCTGGGCCAGCTCAACATGCTGCACAGGAGATCTGGCCTGCCTCGCCCTTCT  GACTCCAATGCTGTGTCCCTGGTGATGAGGAGAATCAGAAAGGAGAATGTGGATGCTGGGGAGAGAGCCAAGC  AGGCCCTGGCCTTTGAACGCACTGACTTTGACCAAGTCAGATCCCTGATGGAGAACTCTGACAGATGCCAGGAC  ATCAGGAACCTGGCCTTCCTGGGCATTGCCTACAACACCCTGCTGCGCATTGCCGAAATTGCCAGAATCAGAGT  GAAGGACATCTCCCGCACCGATGGTGGGAGAATGCTGATCCACATTGGCAGGACCAAGACCCTGGTGTCCACA  GCTGGTGTGGAGAAGGCCCTGTCCCTGGGGGTTACCAAGCTGGTGGAGAGATGGATCTCTGTGTCTGGTGTGG  CTGATGACCCCAACAACTACCTGTTCTGCCGGGTCAGAAAGAATGGTGTGGCTGCCCCTTCTGCCACCTCCCAA  CTGTCCACCCGGGCCCTGGAAGGGATCTTTGAGGCCACCCACCGCCTGATCTATGGTGCCAAGGATGACTCTG  GGCAGAGATACCTGGCCTGGTCTGGCCACTCTGCCAGAGTGGGTGCTGCCAGGGACATGGCCAGGGCTGGTG  TGTCCATCCCTGAAATCATGCAGGCTGGTGGCTGGACCAATGTGAACATTGTGATGAACTACATCAGAAACCTGG  ACTCTGAGACTGGGGCCATGGTGAGGCTGCTCGAGGATGGGGACGGCAGTGGAGGATCCGGAGCCACGAACT  TCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTACCGGTGTGAGCAAGGGCGAGGAGGA  TAACATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCG  AGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGT  GGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACC  CCGCCGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGA  GGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCT  GCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGA  GCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCA  CTACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAAC  ATCAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCC  ACTCCACCGGCGGCATGGACGAGCTGTACAAGGGATATCTCAGCCATGGCTTCCCGCCGGAGGTGGAGGAGCA  GGATGATGGCACGCTGCCCATGTCTTGTGCCCAGGAGAGCGGGATGGACCGTCACCCTGCAGCCTGTGCTTCT  GCTAGGATCAATGTGTGACTCGAGGGCGCGCCTACCCGCGGTAGCTTTTCAGTCGAGAAAAAAACATTAGATCA  GAAGAACAACTGGCAACACTTCTCAACCTGAGACTTACTTCAAGATGCTCGATCCTGGAGAGGTCTATGATGACC  CTATTGACCCAATCGAGTTAGAGGCTGAACCCAGAGGAACCCCCATTGTCCCCAAC Ala88Val mutation in iCre gene of SiR-CRE (1/21 clones)  AGCTGGTT  CAACTCCAACCCTTGGGAGCAATATAACAAAAAACATGTTATGGTGCCATTAAACCGCTGCATTTCATCAAAGTCA  AGTTGATTACCTTTACATTTTGATCCTCTTGGATGTGAAAAAAACTATTAACATCCCTCAAAGGACCTGCAGGTACG  CGGCCGCGGTACCGCCACCATGGTGCCCAAGAAGAAGAGGAAAGTCTCCAACCTGCTGACTGTGCACCAAAAC  CTGCCTGCCCTCCCTGTGGATGCCACCTCTGATGAAGTCAGGAAGAACCTGATGGACATGTTCAGGGACAGGCA  GGCCTTCTCTGAACACACCTGGAAGATGCTCCTGTCTGTGTGCAGATCCTGGGCTGCCTGGTGCAAGCTGAACA  ACAGGAAATGGTTCCCTGCTGAACCTGAGGATGTGAGGGACTACCTCCTGTACCTGCAAGTCAGAGGCCTGGCT  GTGAAGACCATCCAACAGCACCTGGGCCAGCTCAACATGCTGCACAGGAGATCTGGCCTGCCTCGCCCTTCTG  ACTCCAATGCTGTGTCCCTGGTGATGAGGAGAATCAGAAAGGAGAATGTGGATGCTGGGGAGAGAGCCAAGCA  GGCCCTGGCCTTTGAACGCACTGACTTTGACCAAGTCAGATCCCTGATGGAGAACTCTGACAGATGCCAGGACA  TCAGGAACCTGGCCTTCCTGGGCATTGCCTACAACACCCTGCTGCGCATTGCCGAAATTGCCAGAATCAGAGTG  AAGGACATCTCCCGCACCGATGGTGGGAGAATGCTGATCCACATTGGCAGGACCAAGACCCTGGTGTCCACAG  CTGGTGTGGAGAAGGCCCTGTCCCTGGGGGTTACCAAGCTGGTGGAGAGATGGATCTCTGTGTCTGGTGTGGC  TGATGACCCCAACAACTACCTGTTCTGCCGGGTCAGAAAGAATGGTGTGGCTGCCCCTTCTGCCACCTCCCAAC  TGTCCACCCGGGCCCTGGAAGGGATCTTTGAGGCCACCCACCGCCTGATCTATGGTGCCAAGGATGACTCTGG  GCAGAGATACCTGGCCTGGTCTGGCCACTCTGCCAGAGTGGGTGCTGCCAGGGACATGGCCAGGGCTGGTGT  GTCCATCCCTGAAATCATGCAGGCTGGTGGCTGGACCAATGTGAACATTGTGATGAACTACATCAGAAACCTGGA   CTCTGAGACTGGGGCCATGGTGAGGCTGCTCGAGGATGGGGACGGCAGTGGAGGATCCGGAGCCACGAACTT  CTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTACCGGTGTGAGCAAGGGCGAGGAGGAT  AACATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGA  GATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTG  GCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCC  CGCCGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAG  GACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTG  CGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAG  CGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCAC  TACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACA  TCAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCCA  CTCCACCGGCGGCATGGACGAGCTGTACAAGGGATATCTCAGCCATGGCTTCCCGCCGGAGGTGGAGGAGCAG  GATGATGGCACGCTGCCCATGTCTTGTGCCCAGGAGAGCGGGATGGACCGTCACCCTGCAGCCTGTGCTTCTG  CTAGGATCAATGTGTGACTCGAGGGCGCGCCTACCCGCGGTAGCTTTTCAGTCGAGAAAAAAACATTAGATCAGA AGAACAACTGGCAACACTTCTCAACCTGAGACTTACTTCAAGATGCTCGATCCTGGAGAGGTCTATGATGACCCT ATTGACCCAATCGAGTTAGAGGCTGAACCCAGAGGAACCCCCATTGTCCCCAAC Arg189Ile mutation in iCre gene of SiR-CRE  AGCGGGGT  CAACTCCAACCCTTGGGAGCAATATAACAAAAAACATGTTATGGTGCCATTAAACCGCTGCATTTCATCAAAGTCA  AGTTGATTACCTTTACATTTTGATCCTCTTGGATGTGAAAAAAACTATTAACATCCCTCAAAGGACCTGCAGGTACG  CGGCCGCGGTACCGCCACCATGGTGCCCAAGAAGAAGAGGAAAGTCTCCAACCTGCTGACTGTGCACCAAAAC  CTGCCTGCCCTCCCTGTGGATGCCACCTCTGATGAAGTCAGGAAGAACCTGATGGACATGTTCAGGGACAGGCA  GGCCTTCTCTGAACACACCTGGAAGATGCTCCTGTCTGTGTGCAGATCCTGGGCTGCCTGGTGCAAGCTGAACA  ACAGGAAATGGTTCCCTGCTGAACCTGAGGATGTGAGGGACTACCTCCTGTACCTGCAAGCCAGAGGCCTGGC  TGTGAAGACCATCCAACAGCACCTGGGCCAGCTCAACATGCTGCACAGGAGATCTGGCCTGCCTCGCCCTTCT  GACTCCAATGCTGTGTCCCTGGTGATGAGGAGAATCAGAAAGGAGAATGTGGATGCTGGGGAGAGAGCCAAGC  AGGCCCTGGCCTTTGAACGCACTGACTTTGACCAAGTCAGATCCCTGATGGAGAACTCTGACAGATGCCAGGAC  ATCAGGAACCTGGCCTTCCTGGGCATTGCCTACAACACCCTGCTGCGCATTGCCGAAATTGCCAGAATCATAGTG  AAGGACATCTCCCGCACCGATGGTGGGAGAATGCTGATCCACATTGGCAGGACCAAGACCCTGGTGTCCACAG  CTGGTGTGGAGAAGGCCCTGTCCCTGGGGGTTACCAAGCTGGTGGAGAGATGGATCTCTGTGTCTGGTGTGGC  TGATGACCCCAACAACTACCTGTTCTGCCGGGTCAGAAAGAATGGTGTGGCTGCCCCTTCTGCCACCTCCCAAC  TGTCCACCCGGGCCCTGGAAGGGATCTTTGAGGCCACCCACCGCCTGATCTATGGTGCCAAGGATGACTCTGG  GCAGAGATACCTGGCCTGGTCTGGCCACTCTGCCAGAGTGGGTGCTGCCAGGGACATGGCCAGGGCTGGTGT  GTCCATCCCTGAAATCATGCAGGCTGGTGGCTGGACCAATGTGAACATTGTGATGAACTACATCAGAAACCTGGA  CTCTGAGACTGGGGCCATGGTGAGGCTGCTCGAGGATGGGGACGGCAGTGGAGGATCCGGAGCCACGAACTT  CTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTACCGGTGTGAGCAAGGGCGAGGAGGAT  AACATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGA  GATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTG  GCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCC  CGCCGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAG  GACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTG  CGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAG  CGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCAC  TACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACA  TCAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCCA  CTCCACCGGCGGCATGGACGAGCTGTACAAGGGATATCTCAGCCATGGCTTCCCGCCGGAGGTGGAGGAGCAG  GATGATGGCACGCTGCCCATGTCTTGTGCCCAGGAGAGCGGGATGGACCGTCACCCTGCAGCCTGTGCTTCTG  CTAGGATCAATGTGTGACTCGAGGGCGCGCCTACCCGCGGTAGCTTTTCAGTCGAGAAAAAAACATTAGATCAGA Table 1a . All mutations in the SiR-CRE sample at positions mutated at >2% frequency at all stringencies (CCS3, CCS5, CCS8), as well as frameshift mutations found in the C-terminal region of N. Table 2a . All mutations in the SiR-FLPo sample at positions mutated at >2% frequency at all stringencies (CCS3, CCS5, CCS8), as well as frameshift mutations found in the C-terminal region of N.
Supplementary
SiR-CRE
SiR-FLPo
Position Table 2b . Frameshift mutations in the C-terminal region of N in the SiR-FLPo sample at positions mutated at >2% frequency at all stringencies (CCS3, CCS5, CCS8).
RV∆G-4Cre
Position Table 3 . All mutations in the SiR-FLPo sample at positions mutated at >2% frequency at all stringencies (CCS3, CCS5, CCS8).
Tables of all mutations above 2% frequency threshold Table 4a to 4c list all single-nucleotide substitutions and deletions at positions mutated at >2% threshold frequency. The percentage of mutations is calculated based on the total number of single nucleotide and deletion mutations divided by the total number of reads aligned, when insertion mutations are ignored. Deletion mutations dominate in the medium-frequency range between 2% and 5%. Table 4b . SiR-FLPo: substitutions and deletions at positions mutated at >2% frequency at all stringencies (CCS3, CCS5, CCS8).
.
